Skip to main content

StemVAC GmbH

A Subsidiary Of Calidi Biotherapeutics

Our Mission

We Are Revolutionizing The Effective Delivery Of Oncolytic Viruses For Targeted Therapy Against Difficult To Treat Cancers


StemVAC Is A Subsidiary Of Calidi Biotherapeutics

StemVac GmbH

Stephen Thesing

Managing Director for StemVac GmbH
and Chief Business Officer, Calidi Biotherapeutics

Thomas Herrmann, Phd

Associate Vice President, R&D, Process & Assay Development


Am Neuland 1
D-82347 Bernried / Germany

StemVAC is a subsidiary of Calidi Biotherapeutics